Enlarge image
Curevac's first corona vaccine project failed
Photo: Martin Wagner / IMAGO
The biotech company Curevac has sued the vaccine manufacturer Biontech before the Düsseldorf Regional Court.
The company from Tübingen sees its patents being infringed by the competitor from Mainz, which was successful in the pandemic.
The lawsuit is directed against Biontech and two subsidiaries, Curevac announced.
Accordingly, “fair compensation” is required for the violation of a number of its intellectual property rights, which were used in the manufacture and sale of the Covid 19 vaccine Comirnaty by Biontech and its US partner Pfizer.
However, the Tübingen-based company emphasized that it is not planning any injunctions that could impede the production, sale or distribution of Comirnaty.
More soon on SPIEGEL.de
Apr/Reuters
